Protein S deficiency, activated protein C resistance and sticky platelet syndrome in a young woman with bilateral strokes

Cerebrovascular Diseases

Volumn 9, Issue 2, 1999, Pages 127-130

  Chaturvedi, Seemant ^a   Dzieczkowski, Jeffery S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activated protein C resistance; Protein S deficiency; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5; HEPARIN; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; CASE REPORT; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENETIC SCREENING; HEMOSTASIS; HETEROZYGOSITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; STROKE; THROMBOCYTE ADHESIVENESS; THROMBOCYTE DYSFUNCTION; TREATMENT INDICATION;

ADULT; BLOOD COAGULATION DISORDERS; CEREBROVASCULAR DISORDERS; DRUG RESISTANCE; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; PROTEIN C; PROTEIN S DEFICIENCY;

EID: 0033044029     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015911     Document Type: Article

References (27)

1. Nachman RL, Silverstein RL: Hypercoagulable states. Ann Intern Med 1993;119:819-827.
2. Heijboer H, Brandjes DP, Buller HR, Sturk A, ten Cate JW: Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990;323:1512-1516.
3. Coull BW, Clark WM: Abnormalities of hemostasis in ischemic stroke. Med Clin North Am 1993;77(1):77-94.
4. Martinez HR, Rangel-Guerra RA, Marfil LJ: Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke 1993;24:19-25.
5. Dahlback B, Hildebrand B: Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994;91:1396-1400.
6. Bertina RM, Koeleman B, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
7. Mammen EF: Ten years' experience with the sticky platelet syndrome. Clin Appl Thromb Hemost 1995;1:66-72.
8. Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J: Modified test for activated protein C resistance. Lancet 1994;344:1162-1163.
9. Comp PC, Nixon PR, Cooper MR, Esmon CT: Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984;74: 2082.
10. Engesser L, Broekmans AW, Briet E, Brommer EJ, Bertina RM: Hereditary protein S deficiency: Clinical manifestations. Ann Intern Med 1987;106:677-682.
11. Allaart CF, Aronson DC, Ruys T, Rosendaal FR, van Bockel JH, Bertina RM, Briet E: Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost 1990;64:206-210.
12. Girolami A, Simioni P, Lazzaro AR, Cordiano I: Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): A family study. Thromb Haemost 1989;61: 144-147.
13. Cros D, Comp PC, Beltran G, Gum G: Superior sagittal sinus thrombosis in a patient with protein S deficiency. Stroke 1990;21:633-636.
14. Prats JM, Garazar C, Zuazo E, Lopez J, Pinan MA, Aragues P: Superior sagittal sinus thrombosis in a child with protein S deficiency. Neurology 1992;42:2303-2305.
15. Barinagarrementeria F, Cantu Brito C, Izaguirre R, de la Pena A: Progressive intracrancial occlusive disease associated with deficiency of protein S. Report of two cases. Stroke 1993;24:1752-1756.
16. Comp PC: Laboratory evaluation of protein S status. Semin Thromb Hemost 1990;16(2): 177-181.
17. Svensson PJ, Dahlback B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-522.
18. Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A: Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 1995;26:885-890.
19. Van der Bom JG, Bots ML, Haverkate F, Slagboom PE, Meijer P, de Jong PT, Hofman A, Grobbee DE, Kluft C: Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intem Med 1996;125:265-269.
20. Forsyth PD, Dolan G: Activated protein C resistance in cases of cerebral infarction. Lancet 1995;345:795.
21. Press RD, Liu XY, Beamer N, Coull BM: Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. Stroke 1996;27:44-48.
22. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-917.
23. Zoller B, He X, Dahlback B: Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease. Thromb Haemost 1995; 73:743-745.
24. van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdury V, Bauer KA, Scharrer I, Conard J, Lane DA: Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996;75: 417-421.
25. Gandrille S, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M: Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. Blood 1995;86: 219-224.
26. Chaturvedi S, Dzieczkowski J: Multiple hematologic abnormalities in young patients with activated protein C resistance and arterial stroke (abstract). Cerebrovasc Dis 1997; 7 (suppl 4):58.
27. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR: Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-1457.